Ideaya Biosciences Operating Income

Ideaya Biosciences (IDYA) currently reports a operating income of $-460M as of September 2026. That compares with $-210M in the prior-year period — down 121.7% year over year. Use the charts on this page to explore Ideaya Biosciences's operating income history and peer comparisons.

Ideaya Biosciences's operating income decreased from $-210M to $-460M — a 121.7% year-over-year decrease (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Ideaya Biosciences reported $-460M in operating income as of September 2026. That compares with $-210M in the prior-year period — down 121.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-460M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Ideaya Biosciences, and consider following IDYA for alerts when major investors trade the stock.

Ideaya Biosciences is classified in the Healthcare sector. On operating income, it currently shows $-460M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing IDYA with unrelated industries.